A study of irbesartan/amlodipine on hypertensive patients
Not Applicable
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000017785
- Lead Sponsor
- Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Allergy to Irbesartan/Amloipine 2) Renal aretery stenosis of one or both sides 3) Severe liver dysfunction 4) Alcoholic or drug abuse 5) Pregnancy or nursing 6) Myocardial and cerebral infarction in three months 7) Blood tests are as follows. a) AST or ALT more than 2.5 folds or equal to standard values b) Total bilirubin more than or equal to 3.0 mg/dL c) Serum creatinine more than or equal to 2.5 mg/dL d) Serum potassium more than or equal to 5.0 mEq/L 8) Other inappropiate patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood pressure change
- Secondary Outcome Measures
Name Time Method